Thrombotech is dedicated to bringing fundamental improvement to the current treatment for stroke in order to save millions of people from death and disability.
We are developing a drug to improve the safety and efficacy of tPA, the only available stroke medication.
Learn more>>>
“If these results are extended to humans, they could usher in a new era of thrombolytic therapy for stroke, which is the leading cause of disability in the world and the third leading cause of death in the United States after cancer and heart disease”
Johns Hopkins neurologists Ted M Dawson and Valina L Dawson
|
